COMMITMENTS AND CONTINGENCIES
|9 Months Ended
Sep. 30, 2022
|Commitments and Contingencies Disclosure [Abstract]
|COMMITMENTS AND CONTINGENCIES
NOTE 6. COMMITMENTS AND CONTINGENCIES
The holders of the Founder Shares, Private Placement Warrants and Public Warrants that may be issued upon conversion of the Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants issued upon conversion of the Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to consummation of a Business Combination. The Company bears the expenses incurred in connection with the filing of any such registration statements.
In connection with the Initial Public Offering, the underwriters were granted a 45-day option from the date of the Initial Public Offering to purchase up to 24,952,460 to the Company. additional Units to cover over-allotments. On November 16, 2021, the underwriters partially exercised the over-allotment option and purchased an additional Units at an offering price of $ per Unit, generating additional gross proceeds of $
The underwriters received a cash underwriting discount of $0.20 per Unit, or $3,999,049 in the aggregate, which became payable at the closing of the Initial Public Offering. In addition, the underwriters were entitled to a deferred fee of $0.35 per Unit, or $6,998,336 in the aggregate. In July 2022, a portion of the deferred underwriting fee in the amount of $4,898,835 was waived by Goldman Sachs & Co. LLC Securities, Inc., one of the underwriters. Upon IPO, a portion of the entire deferred underwriting fee was allocated to public warrants, which resulted in a charge to the statement of operations. Therefore, a portion of this waived deferred underwriting fee was recorded as a gain in the condensed statements of operations in the amount of $240,082 for the three and nine months ended September 30, 2022. The remaining $4,658,753 was recorded as a reduction to accumulated deficit as of September 30, 2022.
On October 14, 2022, BofA Securities, Inc., the other underwriter, waived the remaining underwriting fee outstanding of $2,099,501 in full. (see Note 10)